Dr. Walter Greenleaf: Known for his research on medical virtual reality, Dr. Greenleaf is at the forefront of how immersive technologies can shape the future of healthcare. His extensive work spans therapeutic game design, neurorehabilitation, and more.
Anand K. Iyer: As the Chief Strategy Officer of WellDoc, a leading digital therapeutic company, Iyer’s work revolves around using technology to manage chronic diseases, emphasizing data-driven approaches to diabetes management.
Dr. Joseph Kvedar: As the Vice President of Connected Health at Partners HealthCare, Dr. Kvedar focuses on deploying technology strategies like remote monitoring and virtual care to enhance patient engagement and improve clinical outcomes.
Alexa B. Kimball, MD, MPH: CEO of Learn to Live, a digital therapeutic platform for mental health. Kimball has been instrumental in advocating for the role of digital platforms in delivering evidence-based mental health interventions.
Pierre Leurent: The CEO and founder of Voluntis, Leurent’s contributions to digital therapeutics include developing software solutions that aid in personalized care, particularly for diabetes and oncology patients.
Corey McCann, M.D., Ph.D.: As the founder of Pear Therapeutics, McCann has been pivotal in the development and commercialization of prescription digital therapeutics, particularly for substance use disorders.
Sean Duffy: Co-founder and CEO of Omada Health, Duffy’s venture focuses on digital intervention programs that tackle chronic diseases, blending data analytics and human-driven interactions for effective patient care.
Eddie Martucci, Ph.D.: CEO of Akili Interactive Labs, Martucci has been pioneering the development of video game experiences designed as therapeutic solutions, particularly for pediatric ADHD and other cognitive dysfunctions.
Dr. Stephen L. Grubbs: As part of the American Society of Clinical Oncology, Dr. Grubbs emphasizes the integration of digital therapeutics into traditional oncology care, ensuring that digital tools complement existing treatment modalities.
Megan Coder, PharmD, MBA: As the Executive Director of the Digital Therapeutics Alliance, Coder plays a pivotal role in broadening the understanding, adoption, and integration of clinically evaluated digital therapeutic solutions across the healthcare landscape.
